GLP1R medications show promise in reducing suicidal ideation among adolescents with obesity

Adolescents treated with GLP1R drugs for obesity exhibit fewer suicidal thoughts, indicating potential mental health benefits of these medications.

Khosla Ventures leads $38M seed round for organoid startup Vivodyne

Khosla Ventures is leading a seed round for a new biotech that aims to use artificial intelligence to jump into the world of organoids. Vivodyne

November 23, 2023

New AI model accurately identifies tumors and diseases in medical images

Medical diagnostics expert, doctor’s assistant, and cartographer are all fair titles for an artificial intelligence model developed by researchers at the Beckman Institute for Advanced

March 5, 2024

Stopping JAK Inhibitor for Severe Alopecia Areata Led to Hair Loss

For patients with severe alopecia areata who had meaningful hair regrowth after 1 year of oral baricitinib (Olumiant) therapy, treatment withdrawal resulted in loss of

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.